Middle East Wound Gel Market (2025 - 2033)

Middle East Wound Gel Market Summary

The Middle East wound gel market size was estimated at USD 137.38 million in 2024 and is projected to reach USD 206.81 million by 2033, growing at a CAGR of 4.67% from 2025 to 2033. The increasing number of surgical procedures is a key driver for the growth of the wound gel market in the Middle East.

Post-operative wounds require effective management to reduce infection risks and enhance healing. Advanced wound care products like wound gels are gaining preference in the region due to their ability to maintain a moist healing environment, promote autolytic debridement, and support faster tissue regeneration, making them essential in post-surgical wound care. The growing aging population in the Middle East is a significant driver of growing demand for the wound gel industry. As the region experiences a rise in age-related diseases such as cardiovascular issues, cancer, diabetes, neurological disorders, and musculoskeletal conditions, the need for surgical interventions increases accordingly.

For instance, according to the study published by Frontiers in February 2025, over half (52%) of the participants had two or more chronic diseases, with hypercholesterolemia, hypertension, and type 2 diabetes being the most common in Saudi Arabia. Wound gels support effective wound management and healing in chronic disease treatments and associated procedures. The growing prevalence of chronic illnesses among older adults drives the adoption of advanced surgical technologies and wound gel products, to improve treatment outcomes and enhance patient recovery in the Middle East.

In addition, the increasing prevalence of diabetes and related complications is anticipated to propel the demand for wound gel products across the Middle East. With a growing number of diabetic patients in the region, there is a higher incidence of chronic wounds such as diabetic foot ulcers and pressure sores, which require advanced wound gel solutions. Wound gels, known for maintaining a moist healing environment and preventing infections, are becoming essential in managing these difficult-to-heal wounds. This rising burden of diabetes and its complications significantly boosts the demand for effective wound gel products across the Middle East. According to the data provided by the International Diabetes Federation (IDF), the prevalence of diabetes is increasing in the Middle East, with countries such as Qatar, Saudi Arabia, and the UAE showing notably high rates among their adult populations. This rising prevalence highlights the growing need for effective diabetes management and related healthcare products, including advanced wound gel solutions, to address complications like diabetic foot ulcers.

Source: IDF

Moreover, the market is expected to grow significantly due to the increasing shift towards digital distribution and online purchasing. Consumers are increasingly turning to e-commerce platforms for convenient access to healthcare products. Key digital retailers like Amazon and eBay are offering wound gels online in the Middle East, enhancing product availability and accessibility across the region. This digital transformation drives market expansion by reaching a broader customer base and simplifying the buying process.

Market Concentration & Characteristics

The market growth stage is high, and the pace of growth is accelerating. The wound gel market in the Middle East is characterized by moderate growth due to rising cases of chronic wounds, diabetic ulcers, and surgical procedures. Increased healthcare spending, improved awareness of advanced wound care, and the presence of international brands are driving market growth across the region.

Ongoing advancements in wound gel have played a crucial role in improving patient recovery, comfort, and overall treatment outcomes. In addition, rising focus on increasing accessibility and distribution of novel wound gels across the Middle East is anticipated to bring innovative products to the market. For instance, in August 2024, Kane Biotech announced a distribution agreement with Razan Medical Trading to bring its revyve Antimicrobial Wound Gel to the Middle Eastern market. This partnership aims to expand the region's access to advanced wound gel solutions, addressing the growing demand for effective treatments for chronic and acute wounds.

Regulatory authorities in the Middle East play a pivotal role in ensuring wound care products' safety, efficacy, and compliance, including gels and dressings. Several national regulatory authorities, such as the Ministry of Health, UAE, and the Saudi Food and Drug Authority (SFDA), authorize medical devices, including wound care products. This process requires manufacturers to provide comprehensive technical documentation, clinical data, and evidence of compliance with international quality standards.

The Middle East wound gel industry presents significant regional expansion opportunities for manufacturers, driven by the increasing prevalence of chronic conditions such as diabetes and cardiovascular diseases. The growing aging population further contributes to the demand for advanced wound care solutions. Key manufacturers are focusing on expanding their presence in high-demand markets like Saudi Arabia and the UAE, capitalizing on government initiatives and investments in healthcare infrastructure to meet the rising need for effective wound management products.

Product Insights

The dressings segment dominated the market in 2024, driven by advancements in materials like hydrogels and silver-based formulations. Hydrogel dressings offer superior moisture retention and pain relief, making them ideal for chronic wounds such as diabetic foot ulcers. Silver-based dressings, known for their broad-spectrum antimicrobial properties, prevent infections in surgical and chronic wounds. The increasing prevalence of chronic conditions and surgical procedures has heightened the demand for these advanced wound gel solutions across the region.

The gel segment is projected to experience the fastest growth at a CAGR of 5.2% over the forecast period. This expansion is driven by the increasing preference for gel formulations due to their versatility, ease of application, and effectiveness in treating acute and chronic wounds. Ongoing research and product innovation further support this segment's rapid growth across the region.

Antimicrobial Properties Insights

In 2024, the silver (Ag+) segment dominated the market in 2024, driven by its broad-spectrum antimicrobial properties that effectively combat infections in chronic wounds such as diabetic foot ulcers and pressure sores. This segment is projected to grow at the fastest CAGR of 5.1% during the forecast period, reflecting its critical role in advanced wound management. The increasing adoption of silver-based gels in hospital and home care settings across the region is expected to bolster this growth further.

The non-silver segment in the market is projected to experience significant growth from 2025 to 2033. This expansion is driven by a rising preference for safer, biocompatible alternatives to metal-based treatments. Concerns over allergic reactions and cytotoxic effects associated with silver have led to increased adoption of natural ingredients such as honey, iodine, and collagen. These natural components offer antimicrobial properties and promote healing, aligning with the region's broader trend toward personalized and gentler treatment options for chronic and acute wounds.

Application Insights

The chronic wounds segment held the largest revenue share in 2024. This dominance is driven by the high prevalence of chronic wounds in the region and the associated healthcare challenges. According to the Journal of Pioneering Medicines published in April 2025, 0.31% to 0.7% of adults aged 65 and older receiving basic medical care develop pressure ulcers annually. This high incidence highlights the growing need for effective wound management solutions, making pressure ulcers a key driver of the market in the Middle East. The region's aging population and rising chronic care demands further fuel market growth.

The acute wounds segment is projected to be the fastest-growing from 2025 to 2033, fueled by a steady rise in burn injuries, surgical procedures, and trauma-related cases across the region. Increasing healthcare access, improving emergency response systems, and expanding surgical infrastructure contribute to the growing demand for effective wound gel solutions.

Mode of Purchase Insights

The prescription segment dominated the market in 2024, driven by the high dependence on physician-guided and hospital-administered treatments for managing chronic, post-surgical, and severe wounds. These gels often contain advanced formulations-such as antimicrobial and healing-promoting agents-making them essential in clinical settings. The growing burden of diabetes-related ulcers, pressure injuries, and surgical wounds across the region continues to fuel demand for prescription wound gel solutions.

The non-prescription segment in the market is projected to experience robust growth from 2025 to 2033, driven by several key factors. Consumers are getting increasingly aware of basic wound care and are opting for self-treatment of minor injuries. The growing availability of over-the-counter (OTC) wound gels in pharmacies and online platforms further facilitates this shift. In addition, product formulations and packaging advancements enhance convenience and safety, making non-prescription wound gels a preferred choice for managing everyday cuts, burns, and abrasions at home.

Distribution Channel Insights

The offline segment held the largest market share in 2024. This dominance is mainly due to the widespread availability of wound gel products across hospitals, pharmacies, and medical supply stores, where healthcare professionals often assist in product selection. In the region, offline channels remain the preferred choice for clinical-grade wound gels, supported by trust in face-to-face consultations and the immediate access to treatment solutions.

The online segment is expected to grow strongly in the market from 2025 to 2033. This expansion is fueled by a growing preference for the convenience of e-commerce platforms, broader product accessibility, and the rising adoption of digital health solutions. The increasing use of telemedicine and direct-to-consumer sales also encourages patients and caregivers to purchase wound gel products online. Improved logistics, secure payment systems, and competitive pricing are further contributing to the rapid rise of the online segment in the region.

End-use insights

The hospitals segment dominated the market with a revenue share of 40.89% in 2024. This dominance is attributed to the high volume of surgical procedures and the need for advanced wound care treatments. Hospitals benefit from access to specialized products like antimicrobial gels, supported by trained medical staff and infrastructure. The rising prevalence of chronic wounds and post-operative care needs further reinforce hospitals' central role in the market. In addition, government initiatives and investments in healthcare infrastructure are enhancing hospitals' capabilities to manage complex wound cases, contributing to the segment's growth.

The home care settings segment is projected to experience the fastest CAGR from 2025 to 2033. This surge is attributed to the increasing preference for at-home treatment, particularly among elderly and chronically ill patients. The availability of user-friendly wound gel products, advancements in telehealth, and rising healthcare cost awareness are encouraging a shift from institutional care to home-based management. This trend reflects the growing demand for convenience, personalized care, and reduced hospital visits.

Country Insights

The wound gel industry in the UAE is experiencing growth, driven by increasing awareness of advanced wound gel solutions and rising demand for effective treatments that promote faster healing. One of the key factors contributing to this growth is the surge in injuries and wound cases resulting from road accidents. UAE Stats show that the number of road accidents in the UAE has increased from 2021 to 2023, leading to a higher incidence of trauma-related wounds. This rise in injuries is directly fueling the demand for wound gels, which are widely used to manage and treat wounds, supporting the expanding wound gel market in the region.

The wound gel industry in Kuwait is driven by the rising prevalence of diabetes as a primary health concern and a key driver in the increased demand for wound gel products. As of 2024, approximately 25.6% of the adult population in Kuwait, over 908,000 individuals, are living with diabetes. Several factors, including sedentary lifestyles, high rates of obesity, urbanization, and dietary habits rich in sugar and processed foods, drive this surge. In addition, a growing aging population and limited public awareness around the prevention of diabetes further contribute to the rising incidence. As more individuals are diagnosed, the number of diabetes-related complications, particularly diabetic foot ulcers, is also increasing. These chronic wounds require specialized treatment, leading to greater usage of wound gels, which help maintain a moist healing environment, prevent infection, and support faster tissue regeneration. This makes the diabetic population a key market driver for the wound gel segment in Kuwait.

Source: IDF 2025

Key Middle East Wound Gel Company Insights

Mölnlycke Health Care AB, Medline Industries, LP, and Coloplast A/S are among the major players in the Middle East wound gel industry. Companies are expanding their portfolios and focusing on partnerships to meet the growing demand. Moreover, industry players are also launching innovative products to gain a competitive advantage.

Recent Development

• In February 2025, Tamer Mölnlycke Care-a joint venture between Mölnlycke Health Care and the Tamer Group-was officially inaugurated in Jeddah, Saudi Arabia. This milestone marks a significant step in strengthening regional healthcare capabilities. The facility is set to manufacture and distribute Mölnlycke wound care products, serving Saudi Arabia and surrounding markets.

Middle East Wound Gel Market